Proteome Profiling Identifies CDH2 as a Potential Screening Marker for

Introduction

Nonalcoholic fatty liver disease (NAFLD), affecting about 30% of the global population, is a prevalent chronic liver condition that closely related metabolic disorders such as obesity, type 2 diabetes mellitus, and dyslipidaemia.^1,2…